CG Oncology IPO rockets 96% in sign of pent-up deal …
CGON Stock Price | CG Oncology Inc. Stock Quote (U.S.: Nasdaq ...Headlines for CG Oncology Inc. (NAS:CGON) - BigCharts
OFF
CG Oncology IPO Rockets 96% In Sign Of Pent-up Deal …
4 weeks from now
CGON Stock Price | CG Oncology Inc. Stock Quote (U.S.: Nasdaq ...Headlines for CG Oncology Inc. (NAS:CGON) - BigCharts
marketwatch.com
OFF
CG Oncology IPO Rockets 96% In Sign Of Pent-up Deal Demand
4 weeks from now
Jan 25, 2024 · Irving, Calif.-based CG Oncology's stock (CGON) closed its first day of trading at $37.17 a share, up 95.6% from its $19 IPO price and well above its opening trade of $29 a share.
morningstar.com
OFF
CG Oncology IPO Rockets 96% In Sign Of Pent-up Deal Demand
4 weeks from now
The cancer-drug company CG Oncology Inc. priced its initial public offering above its estimated range and added 3 million shares to the deal, in a bullish sign ahead of its trading debut …
msn.com
OFF
CGON Stock Price Quote - Morningstar
4 weeks from now
Nov 22, 2024 · CG Oncology Inc. CG Oncology Inc CGON. Stock XNAS Rating as of Nov 22, 2024. Download PDF. Summary; ... CG Oncology IPO rockets 96% in sign of pent-up deal …
morningstar.com
OFF
Biotech CG Oncology Soars 96% In Debut After Expanded IPO (2)
4 weeks from now
Jan 25, 2024 · CG Oncology Inc. shares nearly doubled after the biotechnology company raised $380 million in an initial public offering, in the largest single-day increase this year for a US …
bloomberglaw.com
OFF
CG Oncology Prices Larger-than-expected $380M IPO In Hopeful …
4 weeks from now
Jan 24, 2024 · Cancer drug developer CG Oncology has raised $380 million in an initial public offering than was larger than it expected, a positive sign for a sector that’s struggled to …
biopharmadive.com
OFF
CGON Stock Price | CG Oncology Inc. Stock Quote (U.S.: Nasdaq ...
4 weeks from now
4 days ago · CGON | Complete CG Oncology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... CG Oncology IPO rockets 96% in …
marketwatch.com
OFF
US IPO Weekly Recap: Biotech CG Oncology Pops 96% In A 7 IPO …
4 weeks from now
Jan 26, 2024 · Seven IPOs priced this past week, led by three that raised $100+ million. After upwardly revising the terms earlier in the week, CG Oncology further upsized the offering and …
renaissancecapital.com
OFF
UPDATE 2-Drug Developer CG Oncology Targets Up To $306 Mln …
4 weeks from now
Jan 23, 2024 · Cancer drug developer CG Oncology said on Tuesday it was aiming to raise up to $306 million in its upsized initial public offering in New York, underscoring the resurgent …
yahoo.com
OFF
CG Oncology, Inc. (CGON) Stock Price, Quote & News - Stock …
4 weeks from now
5 days ago · CG Oncology CGON.O notched up a valuation of $1.75 billion in its market debut on Thursday, after shares of the cancer drug developer rose 52.6% at the open on the Nasdaq. …
stockanalysis.com
OFF
American Healthcare REIT, Fortegra And Fractyle Health Set IPO …
4 weeks from now
Jan 29, 2024 · American Healthcare REIT eyes $869M in proceeds as the largest of the three after a strong debut of CG Oncology and a weak open from BrightSpring last week ... CG …
morningstar.com
OFF
CG Oncology Announces Upsized $437 Million IPO - Cooley
4 weeks from now
New York – January 29, 2024 – Cooley advised the underwriters of CG Oncology, a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential …
cooley.com
OFF
CG Oncology Valued At $1.75 Bln In Strong Market Debut - Nasdaq
4 weeks from now
Jan 25, 2024 · Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as demand for new …
nasdaq.com
OFF
CG Oncology Targets Near $1 Bln Valuation In US IPO | Reuters
4 weeks from now
Jan 18, 2024 · At the top end of the proposed range, CG Oncology would raise around $212 million. Morgan Stanley, Goldman Sachs, Cantor and LifeSci Capital are the underwriters for …
reuters.com
OFF
CG Oncology IPO Rockets 96% In Sign Of Pent-up Deal Demand
4 weeks from now
Morningstar brands and products Company Portfolio
morningstar.com
OFF
Cancer Drug Developer CG Oncology Valued At $1.75 Bln In Strong …
4 weeks from now
Jan 25, 2024 · Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as new listings pick up …
reuters.com
OFF
CG Oncology IPO Rockets 96% In Sign Of Pent-up Deal Demand
4 weeks from now
CG Oncology IPO rockets 96% in sign of pent-up deal demand . Pipeline has 2 phase2 drugs and 2 phase3 drugs. That’s all!! Market cap $2.25 Billion. morningstar.com Open. Locked post. …
reddit.com
FAQs about CG Oncology IPO rockets 96% in sign of pent-up deal … Coupon?
Will CG Oncology IPO boost IPO hopefuls?
Why did CG oncology share price double?
How much did CG oncology sell on Wednesday?
Is CG oncology going public?
Does CG oncology have a biotech IPO?
Will CG oncology raise $100 million in a public offering?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
